pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
ELI LILLY CO · news · pharmadog
← back to ELI LILLY CO
News mentioning ELI LILLY CO
230
stories
11d
STAT+: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’
stat
11d
Jupiter enters psychedelics space with $100M deal for PharmAla's MDMA drug
fiercebiotech
12d
Pain drugmaker Latigo outlines plans to go public
biopharma dive
12d
Lilly’s AtaiBeckley buy validates space as Big Pharma takes note of psychedelics
biospace
12d
J&J, AbbVie said to have also looked at AtaiBeckley before Lilly’s $2.8B deal
endpoints
12d
STAT+: A most-wanted fugitive appears to have been secretly working as a biotech executive
stat
12d
Bristol Myers to build ‘powerful’ AI factory; Samsung Biologics bids for peptide maker
biopharma dive
12d
STAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer
stat
12d
Scribe aims for $96M IPO to fund clinical push for lipid-lowering genetic meds
fiercebiotech
12d
STAT+: Telemedicine company touted by Novo Nordisk stressed profits over patient safety, ex-workers say
stat
12d
Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence
biospace
14d
‘A rising tide scenario’: Why other Big Pharmas could follow Lilly into psychedelics
fiercebiotech
15d
STAT+: The end for GSK’s chronic cough treatment
stat
15d
Compounders maintain a firm grip on the GLP-1 market
biopharma dive
15d
STAT+: Pharmalittle: We’re reading about rising drug shortages, GSK coughing up a trial loss, and more
stat
15d
Zealand Pharma gets its US marketing leader from Lilly; Bexorg turns to Biohaven for CSO hire
endpoints
15d
STAT+: Can ultrasound unlock the power of gene therapy? A startup makes big claims
stat
15d
Predicting biotech clinical trials and a new Alzheimer’s drug controversy
stat
16d
Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics
biopharma dive
16d
Veradermics keeps ‘momentum going’ as baldness drug helps women with hair loss
biopharma dive
16d
STAT+: Brain implant restores the sensation of touch in a person with quadriplegia
stat
16d
Lilly makes up to $3.8B psychedelics play in AtaiBeckley takeover
biospace
16d
STAT+: FDA approves Merck’s oral PCSK9 drug, a first
stat
16d
Braveheart, Attovia, Vogenx keep IPOs ballooning with plans to compete in cardiometabolic, immuno
biospace
16d
STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals
stat
16d
STAT+: Eli Lilly to acquire psychedelics-focused biotech AtaiBeckley
stat
16d
Lilly bets $2.8B upfront on psychedelics in deal to buy AtaiBeckley
endpoints
17d
Eli Lilly invests in Oura to support patients on GLP-1 drugs
endpoints
17d
J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals
biopharma dive
17d
STAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and more
stat
← prev
page 3 of 8
next →
